Previous 10 | Next 10 |
Ossen Innovation (NASDAQ: OSN ) +91% on 1H results . More news on: Ossen Innovation Co., Ltd., Sears Hometown and Outlet Stores, Inc., KBS Fashion Group Limited, Stocks on the move, Read more ...
PLANO, Texas, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that its Board of Directors has decided to explore potential strategic alternatives to enhance shareholder value. The Company is currently evaluati...
Nuvectra Corporation (NVTR) Q2 2019 Earnings Conference Call July 31, 2019 04:30 PM ET Company Participants Tram Bui - The Ruth Group Fred Parks - Chief Executive Officer Jennifer Kosharek - Interim CFO Conference Call Participants Conference Call Participants Matthew O'B...
Nuvectra Corporation (NASDAQ: NVTR ): Q2 GAAP EPS of -$0.62 beats by $0.19 . More news on: Nuvectra Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
PLANO, Texas, July 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended June 30, 2019. Recent Business Highlights Algovita ® revenues increased 7% year-over...
Gainers: DelMar Pharmaceuticals (NASDAQ: DMPI ) +39%. SigmaTron International (NASDAQ: SGMA ) +22% . Nuvectra Corporation (NASDAQ: NVTR ) +20% . Teradyne (NASDAQ: TER ) +18% . Manhattan Associates (NASDAQ: MANH ) +18% . Snap (NYSE: SNAP ) +16% . Acasti Pharma (NASDAQ: ACS...
PLANO, Texas, July 17, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended June 30, 2019 on Wednesday, July 31, 2019 after market close. Nuvectra w...
PLANO, Texas, June 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that members of management are scheduled to participate in two upcoming investor conferences in New York, NY. Webcasts of the Company’s p...
Gainers: MX +16.9% . AXGT +15.5% . MAT +8.7% . NBY +6.7% . NVTR +5.5% . More news on: MagnaChip Semiconductor Corporation, Axovant Gene Therapies Ltd., Mattel, Inc., Stocks on the move, , News on ETFs Read more ...
PLANO, Texas, June 11, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the U.S. Food and Drug Administration (FDA) for full-body MR-conditional approval for the Company&...
News, Short Squeeze, Breakout and More Instantly...
Court-Supervised Process Has No Impact on Safety or Functionality of Algovita Device; Company Continuing to Support Physicians PLANO, Texas, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR) (“Nuvectra” or the “Company”), a neurostimulati...
PLANO, Texas, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced it has submitted supplementary chemical composition and biocompatibility data to the U.S. Food and Drug Administration (FDA) in support of the Comp...
PLANO, Texas, Sept. 20, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the appointment of Jennifer Kosharek as Chief Financial Officer, effective September 16, 2019. Ms. Kosharek will assume the role of Chief Financia...